GEN Exclusives

More »

GEN News Highlights

More »
Sep 23, 2008

BD Invests $4.5M in U.S. Genomics and Enters Diagnostic Partnership

  • BD (Becton, Dickinson and Company) made a $4.5 million equity investment in U.S. Genomics and entered into a collaboration to develop an infectious disease diagnostic platform.

    The partnership will leverage U.S. Genomics' DirectLinear Analysis (DLA) technology for the detection of infectious organisms in a single test.

    U.S. Genomics reports that it has invested in excess of $50 million in DLA technology, which integrates labeling strategies, advanced microfluidics, and optical engineering. It enables the identification of pathogens by analyzing individual DNA molecules present in a clinical sample.

    DLA has the potential to provide information such as which drugs a specific pathogen may be resistant to and which drugs could be used for most effective patient treatment, according to the companies.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Companion Animal Care

Do you think Americans spend too much on companion animal care?